Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatmentEJSOIF2.92024-12-010PRE
Incidence, epidemiology, and management of severe biliary pancreatitisBRITISH JOURNAL OF SURGERYIF8.72024-08-020OA
Risk of complications following intraoperative rendezvous ERCP as compared to conventional ERCPBRITISH JOURNAL OF SURGERYIF8.72024-08-020OA
ToF-SIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanomaPIGMENT CELL & MELANOMA RESEARCHIF2.62024-06-294OA
The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial)EJSOIF2.92024-06-013OAAI
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study免疫检查点阻断对有或没有淋巴结转移的黑色素瘤的疗效-一项多中心队列研究EUROPEAN JOURNAL OF CANCERIF7.12022-07-0117OA
Sentinel lymph node localization and staging with a low-dose of superparamagnetic iron oxide (SPIO) enhanced MRI and magnetometer in patients with cutaneous melanoma of the extremity - The MAGMEN feasibility studyEJSOIF2.92022-02-0113OAAI
Health-related quality of life using the FACT-M questionnaire in patients with malignant melanoma: A systematic reviewEJSOIF2.92022-02-014OAAI
ASO Author Reflections: Effects of the Updated AJCC Classification for Patients with Stage III MelanomaANNALS OF SURGICAL ONCOLOGYIF3.52019-08-290OAAI
Is blood a necessary component of the perfusate during isolated limb perfusion - a randomized controlled trialINTERNATIONAL JOURNAL OF HYPERTHERMIAIF32019-08-274OAAI
A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in SwedenANNALS OF SURGICAL ONCOLOGYIF3.52019-05-2015OAAI
BRAF status as a predictive factor for response in isolated limb perfusionINTERNATIONAL JOURNAL OF HYPERTHERMIAIF32019-04-152OAAI
Sentinel node for malignant melanoma: An observational study of a consecutive single centre experienceEJSOIF2.92019-02-013PREAI
Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant MelanomaANNALS OF SURGICAL ONCOLOGYIF3.52019-01-0713OAAI
Minimally invasive isolated limb perfusion - technical details and initial outcome of a new treatment method for limb malignanciesINTERNATIONAL JOURNAL OF HYPERTHERMIAIF32018-11-145OAAI
ASO Author Reflections: The Future of Isolated Limb PerfusionANNALS OF SURGICAL ONCOLOGYIF3.52018-11-080PREAI
The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb PerfusionANNALS OF SURGICAL ONCOLOGYIF3.52018-05-1512OAAI